E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

Pharma-50-transparent_216px_red

Become a Fan

« Patent Profile: Helix BioMedix Announces Issuance of Patent for Antimicrobial Peptide | Main | ABA Issues Opinion on Outsourcing »

August 26, 2008

Comments

Kevin,

Given that Chief Judge Michel authored this opinion, I agree with you that this may signal a trend by the Federal Circuit to reign in dubious or weakly supported allegations of inequitable conduct. If true, that would be "good news" for patentees and those of us in the prosecution world who have to worry that every action we take during prosecution will be misconstrued, mischaracterized, or distorted. Only time will tell.

The comments to this entry are closed.

May 2017

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31